PatentsUSA
SK Biopharmaceuticals and MSN Laboratories Reach Settlement in U.S. Patent Dispute Over XCOPRI®
SK Biopharmaceuticals has amicably resolved its U.S. patent litigation with Indian generic manufacturer MSN Laboratories concerning the epilepsy drug cenobamate, marketed as XCOPRI®. The settlement grants MSN Laboratories rights to launch a generic version under agreed patent terms, concluding the dispute in the Distr…
Wednesday, August 19, 2026